Lawrence Wesley Golby - 12 Nov 2021 Form 3 Insider Report for ACACIA RESEARCH CORP (ACTG)

Role: Director of Research
Signature: /s/ Jennifer Graff, Attorney in fact
Issuer symbol: ACTG
Transactions as of: 12 Nov 2021
Net transactions value: $0
Form type: 3
Filing time: 22 Nov 2021, 17:38:11 UTC
Next filing: 10 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ACTG	ACTG Common Stock						80,000	12 Nov 2021	Direct	F1
holding	ACTG	ACTG Common Stock						45,000	12 Nov 2021	Direct	F2
holding	ACTG	ACTG Common Stock						20,000	12 Nov 2021	Direct	F3
holding	ACTG	ACTG Common Stock						6,700	12 Nov 2021	By: Daughters	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ACTG	Stock Option (Right to Buy)							12 Nov 2021	Acacia Research Corporation Common Stock	112,500	$5.84	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This award of restricted stock awards ("RSAs") is made pursuant to the 2013 Acacia Research Corporation Stock Incentive Plan. The RSAs vest annually in equal installments over three years starting from August 1, 2020 (the "Grant Date"), such that the RSAs shall be fully vested on the date which is three years from the Grant Date.
F2	This award of restricted stock units ("RSUs") is made pursuant to the 2016 Acacia Research Corporation Stock Incentive Plan. The RSUs will vest annually in equal installments on the date of each of the Company's 2022, 2023 and 2024 Annual Meeting of Stockholders, respectively.
F3	These shares are held in two IRA accounts in the reporting person's name.
F4	These shares are held in trusts for the benefit of the minor daughters of the reporting person and for which the reporting person is an investment advisor.
F5	One third of the option shares will vest and be exercisable on the date of each of the Company's 2022, 2023 and 2024 Annual Meeting of Stockholders, respectively.